Shanghai Haohai Biological Technology Co Ltd banner

Shanghai Haohai Biological Technology Co Ltd
SSE:688366

Watchlist Manager
Shanghai Haohai Biological Technology Co Ltd Logo
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Watchlist
Price: 45.91 CNY -1.21% Market Closed
Market Cap: ¥10.6B

Wall Street
Price Targets

Price Targets Summary
Shanghai Haohai Biological Technology Co Ltd

Wall Street analysts forecast Shanghai Haohai Biological Technology Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai Haohai Biological Technology Co Ltd is 63.7 CNY with a low forecast of 60.6 CNY and a high forecast of 68.16 CNY.

Lowest
Price Target
60.6 CNY
32% Upside
Average
Price Target
63.7 CNY
39% Upside
Highest
Price Target
68.16 CNY
48% Upside
Shanghai Haohai Biological Technology Co Ltd Competitors:
Price Targets
FBIZ
First Business Financial Services Inc
18% Upside
OFIX
Orthofix Medical Inc
53% Upside
PTGX
Protagonist Therapeutics Inc
25% Upside
NN
NextNav Inc
28% Upside
BRI
Britania PCL
5% Upside

Revenue
Forecast

10% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
10% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 7 years the compound annual growth rate for Shanghai Haohai Biological Technology Co Ltd's revenue is 10%. The projected CAGR for the next 3 years is 6%.

Operating Income
Forecast

0% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss
0% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss

For the last 7 years the compound annual growth rate for Shanghai Haohai Biological Technology Co Ltd's operating income is 0%. The projected CAGR for the next 3 years is 16%.

Net Income
Forecast

2% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
2% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 7 years the compound annual growth rate for Shanghai Haohai Biological Technology Co Ltd's net income is 2%. The projected CAGR for the next 3 years is 17%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai Haohai Biological Technology Co Ltd's stock price target?
Price Target
63.7 CNY

According to Wall Street analysts, the average 1-year price target for Shanghai Haohai Biological Technology Co Ltd is 63.7 CNY with a low forecast of 60.6 CNY and a high forecast of 68.16 CNY.

What is Shanghai Haohai Biological Technology Co Ltd's Revenue forecast?
Projected CAGR
6%

For the last 7 years the compound annual growth rate for Shanghai Haohai Biological Technology Co Ltd's revenue is 10%. The projected CAGR for the next 3 years is 6%.

What is Shanghai Haohai Biological Technology Co Ltd's Operating Income forecast?
Projected CAGR
16%

For the last 7 years the compound annual growth rate for Shanghai Haohai Biological Technology Co Ltd's operating income is 0%. The projected CAGR for the next 3 years is 16%.

What is Shanghai Haohai Biological Technology Co Ltd's Net Income forecast?
Projected CAGR
17%

For the last 7 years the compound annual growth rate for Shanghai Haohai Biological Technology Co Ltd's net income is 2%. The projected CAGR for the next 3 years is 17%.

Back to Top